
Lion Capital to fully exit Weetabix
Lion Capital is reportedly in the process of selling its 40% stake in UK cereal manufacturer Weetabix to majority backer Bright Food Group, in a deal valuing the business at £1.28bn.
Bloomberg reports the stake would in turn be sold to Hong Kong-based Baring Private Equity, citing "people with knowledge of the matter".
Lion sold a 60% stake in the company to Bright Food in 2012 in a deal valuing the company at £1.2bn. The transaction meant the firm reportedly generated a 3x return on its initial investment, including several dividend payments.
At the time of the deal, it was anticipated Lion would generate a 5x return once Weetabix had been fully exited. The partial sale came shortly after the cereal producer restructured £900m of its debt.
The GP – then known as Hicks Muse Tate & Furst – took Weetabix private in 2004 in a deal that valued the business at £642m.
A spokesperson for Baring could not be reached prior to publication, while a spokesperson for Lion declined to comment.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater